^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PBCAR 20A

    i
    Other names: PBCAR20A, PBCAR 20A
    Associations

    News

    Trials
    Company:
    Precision BioSci
    Drug class:
    CD20-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over2years
    Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (clinicaltrials.gov)
    P1/2, N=17, Completed, Precision BioSciences, Inc. | Recruiting --> Completed | N=90 --> 17
    Trial completion • Enrollment change
    |
    CD20 (Membrane Spanning 4-Domains A1)
    |
    cyclophosphamide • fludarabine IV • PBCAR 20A